In the process of glycogen metabolism, the low expression of PGM1 hindered the glycogen synthesis pathway of tumor cells, making glucose more used in the glycolysis process, thereby promoting tumor cell proliferation and the malignant progression of HCC (Jin et al., 2018). This evidence concerns the gene PGM1 and neoplasm.